
Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

Research

Featured research

Truveta graphic highlighting a JMCP study of real-world switching from Humira (adalimumab) to biosimilars in the United States, with a line chart showing increased biosimilar adoption after formulary changes.

Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar

A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.

Read More
Research graphic highlighting rising progesterone-containing hormone replacement therapy use among women from 2018 to 2026.

Progesterone-containing hormone replacement therapy use is rising

Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.

Read More

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular